1,2-dipalmitoylphosphatidylcholine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| White, JC; Wright, SE | 1 |
| Fujii, Y; Okimasu, E; Utsumi, K; Utsumi, T; Yamamoto, M | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Membrane ordering effects of the anticancer agent VM-26.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Cholesterol; Cyclic N-Oxides; Dimyristoylphosphatidylcholine; Electron Spin Resonance Spectroscopy; Etoposide; Humans; Leukemia; Lipid Bilayers; Liposomes; Male; Membrane Lipids; Mice; Podophyllotoxin; Spin Labels; Teniposide | 1986 |
Cytoplasmic proteins, association with phospholipid vesicles and its dependency on cholesterol.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Ehrlich Tumor; Cell Membrane Permeability; Cholesterol; Cytoplasm; Dose-Response Relationship, Drug; Intracellular Membranes; Liposomes; Membrane Fluidity; Phospholipids; Rats | 1986 |